100Xfounder
Menu
Get Featured
Cambridge Epigenetix logoCE

Cambridge Epigenetix

Verified
Visit WebsiteConnect with Founders

Cambridge Epigenetix is using epigenetics to reduce diagnostic tests for common cancers to a simple blood draw. Biotech Healthcare Medical

About Cambridge Epigenetix

Cambridge Epigenetix builds in the startup category and is tracked by 100Xfounder for operating momentum, talent growth, and market execution.

What they do: Cambridge Epigenetix is using epigenetics to reduce diagnostic tests for common cancers to a simple blood draw. Biotech Healthcare Medical

Funding context: Sequoia, $88M Series D in 2021, $350M valuation

Recent milestones:

  • Cambridge Epigenetix appears in the 100Xfounder startup directory import feed.

Why it Matters

Cambridge Epigenetix matters because cambridge Epigenetix is using epigenetics to reduce diagnostic tests for common cancers to a simple blood draw. Biotech Healthcare Medical

Funding Snapshot

Total Funding: $88.00MLast Round: Series D Sequoia, $88M Series D in 2021, $350M valuationAll Rounds: 1
  • Series D | Sequoia, $88M Series D in 2021, $350M valuation

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Cambridge Epigenetix Team

Cambridge Epigenetix Team

Founder & CEO

LinkedIn

Tech Stack

AWSReactPythonPostgreSQL

Last updated: April 17, 2026

Cambridge Epigenetix intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Startup with comparable market signals.

Varda logoV
Varda

Varda Team

View CompanyCompare Alternatives
Flexport logoF
Flexport

Flexport Team

View CompanyCompare Alternatives
DevRev logoD
DevRev

DevRev Team

View CompanyCompare Alternatives
insitro logoI
insitro

insitro Team

View CompanyCompare Alternatives
PatSnap logoP
PatSnap

PatSnap Team

View CompanyCompare Alternatives
Solugen logoS
Solugen

Solugen Team

View CompanyCompare Alternatives
Gong.io logoG
Gong.io

Gong.io Team

View CompanyCompare Alternatives
Klook logoK
Klook

Klook Team

View CompanyCompare Alternatives

Discover Now

Newsroom and topic pages connected to Cambridge Epigenetix.

Company News HubTopic HubsFunding News

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Company profile→Company news hub→Founder profile→United Kingdom startup directory→United Kingdom startup news→Startup hub→Startup startup list→Series D startups→Series D startup list→Series D newsroom→

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

Contact EditorialGet Featured

FAQs About Cambridge Epigenetix

Common questions people ask about this profile.

What is Cambridge Epigenetix?

Cambridge Epigenetix is using epigenetics to reduce diagnostic tests for common cancers to a simple blood draw. Biotech Healthcare Medical

Who founded Cambridge Epigenetix?

Cambridge Epigenetix is associated with Cambridge Epigenetix Team on 100Xfounder.

Where is Cambridge Epigenetix located?

Cambridge Epigenetix is listed in London, England, United Kingdom.

What stage is Cambridge Epigenetix in?

Cambridge Epigenetix is currently mapped to Series D. Funding context: Sequoia, $88M Series D in 2021, $350M valuation

What is the latest funding round of Cambridge Epigenetix?

Cambridge Epigenetix's latest tracked round is Series D Sequoia, $88M Series D in 2021, $350M valuation. Total tracked rounds: 1.

Is Cambridge Epigenetix hiring now?

Cambridge Epigenetix hiring status: Open Roles.

What technologies does Cambridge Epigenetix use?

Cambridge Epigenetix is associated with AWS, React, Python, and PostgreSQL.

Is Cambridge Epigenetix verified on 100Xfounder?

Yes. Cambridge Epigenetix is currently marked verified on 100Xfounder as of April 17, 2026.

How can users connect with Cambridge Epigenetix founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.